Publications by authors named "Andrew Cutler"

Claim this Profile
E
Economic, clinical, and humanistic burden associated with major depressive disorder with prominent anhedonia in the United States: analysis of Medical Expenditure Panel Survey.
Hrishikesh Kale, Michael L Ganz, Rajrupa Ghosh, Cynthia Saiontz-Martinez, Tiina Drissen, Andrew J Cutler

J Affect Disord· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review.
Amita R Patel, Robert A Hauser, Leslie Citrome, Laxman Bahroo, Tracy Hicks, Andrew J Cutler

CNS Spectr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing LAIs: from completing the first injection to going steady.
Andrew J Cutler, Meghan M Grady

CNS Spectr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder.
Gregory W Mattingly, Osman Turkoglu, Denise Chang, Caroline Ward, Taisa Skubiak, Andrew J Cutler

J Clin Psychopharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of an Online Assessment of Attention-Deficit/Hyperactivity Disorder Among a Real-World Sample of Adults Seeking Web-Based Mental Health Care.
Barry K Herman, Stephen V Faraone, Andrew J Cutler, Jeffrey H Newcorn, Emily M LaFrance

J Clin Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization 6 Months Before and After Olanzapine/Samidorphan Initiation: Real-World Assessment of Patients with Schizophrenia or Bipolar I Disorder.
Andrew J Cutler, Hemangi R Panchmatia, Alejandro G Hughes, Noah S Webb, Michael J Doane

Adv Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked database.
Hrishikesh Kale, Stevan Geoffrey Severtson, Becca S Feldman, Tiina Drissen, Nilanjana Dwibedi, Andrew J Cutler

BMC Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice.
Craig Chepke, Ruth M Benca, Andrew J Cutler, Andrew D Krystal, Nathaniel F Watson

J Clin Psychiatry· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Counter-propagating fs/ps CARS for sub-100  µm resolution gas-phase thermometry.
Alan J Kim, Ryan J Thompson, Andrew D Cutler, Chloe E Dedic

Appl Opt· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navacaprant, a Novel and Highly Selective Kappa Opioid Receptor Antagonist, in Adults With Major Depressive Disorder: A Randomized, Double-Blind Phase 2 Clinical Trial.
Sanjay J Mathew, Andrew J Cutler, Nicole C Visitacion, Michael Gold, Jason Yuan

J Clin Psychopharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric properties of the Federal Unit Scale for general psychopathology screening without iatrogenic effects.
Tyler M Moore, Kathryn Walker, Franz Hell, Grayson Rosenblad, Andrew Cutler

J Psychiatr Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Leslie Citrome, Christoph U Correll, Andrew J Cutler, Martin Dunbar, Amber R Hoberg

Neuropsychiatr Dis Treat· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the delivery technology used in ADHD stimulant medications can help to individualize treatment.
Andrew J Cutler, Jacob Hanaie

CNS Spectr· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results From the 5-Week, Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials.
Inder Kaul, Amy Claxton, Sharon Sawchak, Colin Sauder, Stephen K Brannan, Andrew J Cutler

J Clin Psychiatry· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting.
Christoph U Correll, Andrew J Cutler, François Laliberté, Guillaume Germain, Sean D MacKnight

Ann Gen Psychiatry· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
Ann Childress, Andrew J Cutler, Lenard A Adler, Nicholas Fry, Kobby Asubonteng

CNS Drugs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs associated with first versus subsequent use of cariprazine for bipolar I disorder.
Andrew J Cutler, François Laliberté, Guillaume Germain, Sean D MacKnight, Julien Boudreau

J Med Econ· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future.
Craig Chepke, Elizabeth Brunner, Andrew J Cutler

Psychopharmacol Bull· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial.
Maurizio Fava, Stephen M Stahl, Luca Pani, Sara De Martin, Andrew J Cutler

J Clin Psychiatry· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis.
Rakesh Jain, Roger S McIntyre, Andrew J Cutler, Willie R Earley, Huy-Binh Nguyen

Int Clin Psychopharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study.
Andrew J Cutler, Scott H Kollins, Matthew N Brams, Meg Corliss, Charles Oh

Front Psychiatry· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating Changes in Weight and Metabolic Parameters Before and After Treatment With Cariprazine: A Retrospective Study of Electronic Health Records.
Prakash S Masand, Roger S McIntyre, Andrew J Cutler, Michael L Ganz, Andrea L Lorden

Clin Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder: Interim Results From the Open-Label, Phase 3 SHORELINE Study.
Andrew J Cutler, Gregory W Mattingly, Susan G Kornstein, Scott T Aaronson, Robert Lasser

J Clin Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative outcomes of middle meningeal artery embolization with statins versus embolization alone in the treatment of chronic subdural hematoma: a systematic review and meta-analysis.
Basel Musmar, Samantha Spellicy, Hamza Salim, Jihad Abdelgadir, Ali Zomorodi, Andrew Cutler

Neurosurg Rev· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis